1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nicardipine in 4 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (nicardipine) | Trials (nicardipine) | Recent Studies (post-2010) (nicardipine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 2,646 | 444 | 312 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | nicardipine (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.314 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 8 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 4.2992 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.42 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 1.69 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2.5 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 1.69 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 4.925 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 4.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avdonin, PV; Svitina-Ulitina, IV; Tkachuk, VA | 1 |
| Clark, JS; Jubb, SN; Maloney, PJ; Young, JM | 1 |
| Arai, Y; Kamata, K; Kasuya, Y | 1 |
| Markey, SP; Nishida, K | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nicardipine
| Article | Year |
|---|---|
Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine.
Topics: Blood Platelets; Calcium; Cytosol; Humans; Nicardipine; Platelet Activating Factor; Spectrometry, Fluorescence; Verapamil | 1988 |
Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse.
Topics: Anaphylaxis; Animals; Chloroquine; Chlortetracycline; Dexamethasone; Dose-Response Relationship, Drug; Female; Indomethacin; Injections, Intravenous; Male; Mice; Mice, Inbred DBA; Naproxen; Nicardipine; Nifedipine; Platelet Activating Factor; Pyrazoles; Quinacrine; Tetracycline; Verapamil | 1985 |
Mechanism of the contractile response to platelet-activating factor (PAF) of the rat stomach fundus. I. PAF-induced contractile response and calcium mobilization.
Topics: Animals; Calcium; Gastric Fundus; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nicardipine; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar | 1993 |
Nicardipine and MK-801 attenuate platelet-activating factor increases following cerebral ischemia-reperfusion in gerbils.
Topics: Analysis of Variance; Animals; Body Temperature; Brain; Cerebral Cortex; Dizocilpine Maleate; Female; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Nicardipine; Organ Specificity; Platelet Activating Factor; Reperfusion; Thalamus; Time Factors | 1996 |